Novanta (NOVT) EBITDA (2010 - 2026)

Novanta (NOVT) has reported EBITDA for 17 consecutive years, with $18.1 million the latest figure, recorded in Q3 2026.

• For the quarter ending Q3 2026, EBITDA rose 21.13% year-over-year to $18.1 million; the trailing twelve-month figure through Jul 2026 stood at $92.3 million (down 13.43% YoY), and the FY2025 full-year result was $94.0 million, down 14.99% from the prior year.
• EBITDA fell to $18.1 million in Q3 2026 per NOVT's latest filing, from $27.5 million in the prior quarter.
• Across five years, EBITDA topped out at $32.6 million in Q3 2024 and bottomed at $14.9 million in Q2 2025.
• Historically, EBITDA has averaged $25.8 million across 5 years, with a median of $26.0 million in 2023.
• The sharpest annual moves came in 2022 and 2025: EBITDA surged 118.79% in 2022, then slumped 42.01% in 2025.
• Over 5 years, EBITDA stood at $26.8 million in 2022, then decreased by 19.25% to $21.7 million in 2023, then climbed by 23.2% to $26.7 million in 2024, then fell by 7.02% to $24.8 million in 2025, then retreated by 27.27% to $18.1 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $18.1 million, $27.5 million, and $24.8 million for Q3 2026, Q2 2026, and Q4 2025 respectively.